Literature DB >> 19572860

Psychogenic syncope? A cautionary note.

Khalil Kanjwal1, Yousuf Kanjwal, Beverly Karabin, Blair P Grubb.   

Abstract

INTRODUCTION: In some patients with recurrent syncope, the etiology may remain unclear despite extensive evaluation. These patients may sometimes be labeled as having a "psychogenic" cause for their syncope.
METHODS: We report on three patients with recurrent unexplained syncope (despite extensive evaluation) who were labeled as having a psychogenic cause for their events. In each patient following placement of an implantable loop recorder, their syncopal events were found to be due to periods of prolonged asystole and/or complete heart block. One patient had prolonged asystole for 44 seconds. In each patient, episodes of syncope were eliminated following permanent pacemaker implantation.
CONCLUSION: We conclude that physicians should exercise great caution before labeling any patient's syncope as psychogenic and that prolonged monitoring may be necessary to exclude a potential cardiac rhythm-related etiology.

Entities:  

Mesh:

Year:  2009        PMID: 19572860     DOI: 10.1111/j.1540-8159.2009.02400.x

Source DB:  PubMed          Journal:  Pacing Clin Electrophysiol        ISSN: 0147-8389            Impact factor:   1.976


  3 in total

1.  The semiology of tilt-induced psychogenic pseudosyncope.

Authors:  Martijn R Tannemaat; Julius van Niekerk; Robert H Reijntjes; Roland D Thijs; Richard Sutton; J Gert van Dijk
Journal:  Neurology       Date:  2013-07-19       Impact factor: 9.910

2.  Recurrent loss of consciousness despite DDD pacing: psychogenic pseudosyncope in a 19-year-old man.

Authors:  Stoyan Popkirov; Wenke Grönheit; Uwe Schlegel; Jörg Wellmer
Journal:  Clin Res Cardiol       Date:  2014-04-23       Impact factor: 5.460

3.  Psychogenic Pseudosyncope: Real or Imaginary? Results from a Case-Control Study in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Patients.

Authors:  C Linda M C van Campen; Frans C Visser
Journal:  Medicina (Kaunas)       Date:  2022-01-09       Impact factor: 2.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.